401k Record

Employers › Coherus Oncology

Coherus Oncology 401(k)

Recordkeeping fees per participant · Coherus Biosciences, Inc. 401(k) Plan · plan year 2024

$17.70

Higher than 16% of the 5,847 plans $50 to 250M that report it.

Source

= $6,885 / 389
Schedule H, line 2i(3); OTH_RECORDKEEPING_FEES_AMT pos 160; filing 20250922110923NAL0012137298001, received 2025-09-22
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250922110923NAL0012137298001, received 2025-09-22

10th: $10.22median $69.9190th: $151.08

Percentiles compare this plan with the Schedule H plans $50 to 250M in assets of the same plan year, excluding final filings; shown only where at least 50 comparable plans report the figure. Plan year 2024-01-01 to 2024-12-31, filing received 2025-09-22.

Cost and contributions

Administrative expenses excluding investment management, per participant

$17.70

10th: $16.21median $93.2090th: $246.84

Higher than 11% of the 8,758 plans $50 to 250M that report it.

Source

= $6,885 / 389
derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20250922110923NAL0012137298001, received 2025-09-22
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250922110923NAL0012137298001, received 2025-09-22

Administrative expenses per participant

$187.33

10th: $29.39median $132.8490th: $350.58

Higher than 68% of the 9,042 plans $50 to 250M that report it.

Source

= $72,872 / 389
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250922110923NAL0012137298001, received 2025-09-22
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250922110923NAL0012137298001, received 2025-09-22

Administrative expenses as a share of assets

0.138%

10th: 0.022%median 0.136%90th: 0.326%

Higher than 51% of the 9,049 plans $50 to 250M that report it.

Source

= $72,872 / $52,744,802
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250922110923NAL0012137298001, received 2025-09-22
assets_eoy: Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20250922110923NAL0012137298001, received 2025-09-22

Employer contributions per participant

$3,753

10th: $965median $2,73890th: $8,164

Higher than 66% of the 9,105 plans $50 to 250M that report it.

Source

= $1,459,978 / 389
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250922110923NAL0012137298001, received 2025-09-22
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250922110923NAL0012137298001, received 2025-09-22

Employer share of total contributions

20.3%

10th: 15.6%median 29.5%90th: 50.6%

Higher than 20% of the 9,112 plans $50 to 250M that report it.

Source

= $1,459,978 / $7,178,625
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250922110923NAL0012137298001, received 2025-09-22
total_contrib: Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20250922110923NAL0012137298001, received 2025-09-22

Plan terms, as stated in Coherus Oncology, Inc.'s SEC filings

Employer match

“The Company makes matching contributions of 100% of the first 4% of eligible compensation that an employee contributes to his or her 401(k) plan, up to a maximum of $7,500 each year.”

Form 10-K filed 2026-03-09, for the year ended 2025-12-31 · benefits note, 10-K benefits note · source document

Terms quoted from the filing for the year ended 2025-12-31. Figures cover plan year 2024. The plan document governs.

Plan features

2E profit-sharing · 2F ERISA 404(c) plan · 2G fully participant-directed · 2J 401(k) feature · 2K 401(m) arrangement · 2T default investment (QDIA) · 3D IRS pre-approved plan · Form 5500, line 8a; TYPE_PENSION_BNFT_CODE pos 81; filing 20250922110923NAL0012137298001, received 2025-09-22

Full record, Coherus Biosciences, Inc. 401(k) Plan

FieldValueSource
Plan sponsorCOHERUS BIOSCIENCES, INC.Form 5500, Part II line 2a; SPONSOR_DFE_NAME pos 19; filing 20250922110923NAL0012137298001, received 2025-09-22
Plan nameCOHERUS BIOSCIENCES, INC. 401K PLANForm 5500, line 1a; PLAN_NAME pos 16; filing 20250922110923NAL0012137298001, received 2025-09-22
Sponsor EIN / plan number27-3615821 / 001Form 5500, line 2b; SPONS_DFE_EIN pos 44; filing 20250922110923NAL0012137298001, received 2025-09-22
Plan typesingle-employerForm 5500, Part I line A; TYPE_PLAN_ENTITY_CD pos 4; filing 20250922110923NAL0012137298001, received 2025-09-22
Sponsor locationREDWOOD CITY, CAForm 5500, line 2a; SPONS_DFE_MAIL_US_STATE pos 25; filing 20250922110923NAL0012137298001, received 2025-09-22
Industry (business code)325410, ManufacturingForm 5500, line 2d; BUSINESS_CODE pos 46; filing 20250922110923NAL0012137298001, received 2025-09-22
Plan year2024-01-01 to 2024-12-31Form 5500, Part I plan year; FORM_PLAN_YEAR_BEGIN_DATE pos 2; filing 20250922110923NAL0012137298001, received 2025-09-22
Filing received2025-09-22Form 5500, EFAST2 receipt date; DATE_RECEIVED pos 102; filing 20250922110923NAL0012137298001, received 2025-09-22
Final filingnoForm 5500, Part I line B; FINAL_FILING_IND pos 8; filing 20250922110923NAL0012137298001, received 2025-09-22
Amended filingnoForm 5500, Part I line B; AMENDED_IND pos 7; filing 20250922110923NAL0012137298001, received 2025-09-22
Participants, beginning of year463Form 5500, line 5; TOT_PARTCP_BOY_CNT pos 71; filing 20250922110923NAL0012137298001, received 2025-09-22
Active participants239Form 5500, line 6a(2); TOT_ACTIVE_PARTCP_CNT pos 72; filing 20250922110923NAL0012137298001, received 2025-09-22
Participants, end of year408Form 5500, line 6f; TOT_ACT_RTD_SEP_BENEF_CNT pos 77; filing 20250922110923NAL0012137298001, received 2025-09-22
Participants with an account balance389Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250922110923NAL0012137298001, received 2025-09-22
Total assets, beginning of year$46,621,056Schedule H, Part I line 1f col (a); TOT_ASSETS_BOY_AMT pos 30; filing 20250922110923NAL0012137298001, received 2025-09-22
Total assets, end of year$52,744,802Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20250922110923NAL0012137298001, received 2025-09-22
Net assets, end of year$52,744,802Schedule H, line 1l col (b); NET_ASSETS_EOY_AMT pos 67; filing 20250922110923NAL0012137298001, received 2025-09-22
Total income$13,412,373Schedule H, Part II line 2d; TOT_INCOME_AMT pos 97; filing 20250922110923NAL0012137298001, received 2025-09-22
Net income$6,123,746Schedule H, line 2k; NET_INCOME_AMT pos 111; filing 20250922110923NAL0012137298001, received 2025-09-22
Employer contributions$1,459,978Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250922110923NAL0012137298001, received 2025-09-22
Participant contributions$5,330,323Schedule H, line 2a(1)(B); PARTICIPANT_CONTRIB_AMT pos 69; filing 20250922110923NAL0012137298001, received 2025-09-22
Other contributions (incl. rollovers)$388,324Schedule H, line 2a(1)(C); OTH_CONTRIB_RCVD_AMT pos 70; filing 20250922110923NAL0012137298001, received 2025-09-22
Total contributions$7,178,625Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20250922110923NAL0012137298001, received 2025-09-22
Benefit payments$7,164,902Schedule H, line 2e(4); TOT_DISTRIB_BNFT_AMT pos 101; filing 20250922110923NAL0012137298001, received 2025-09-22
Total expenses (incl. benefit payments)$7,288,627Schedule H, line 2j; TOT_EXPENSES_AMT pos 110; filing 20250922110923NAL0012137298001, received 2025-09-22
Total administrative expenses$72,872Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250922110923NAL0012137298001, received 2025-09-22
Recordkeeping fees$6,885Schedule H, line 2i(3); OTH_RECORDKEEPING_FEES_AMT pos 160; filing 20250922110923NAL0012137298001, received 2025-09-22
Investment advisory and management fees$65,987Schedule H, line 2i(5); INVST_MGMT_FEES_AMT pos 107; filing 20250922110923NAL0012137298001, received 2025-09-22
Administrative expenses excluding investment management$6,885derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20250922110923NAL0012137298001, received 2025-09-22
Held in common/collective trusts$2,597,029Schedule H, line 1c(9) col (b); INT_COMMON_TR_EOY_AMT pos 51; filing 20250922110923NAL0012137298001, received 2025-09-22
Held in mutual funds$48,388,344Schedule H, line 1c(13) col (b); INT_REG_INVST_CO_EOY_AMT pos 55; filing 20250922110923NAL0012137298001, received 2025-09-22
Independent auditorBPM LLPSchedule H, Part III line 3a; ACCOUNTANT_FIRM_NAME pos 116; filing 20250922110923NAL0012137298001, received 2025-09-22

Position = column in the DOL layout for form year 2024. Filing 20250922110923NAL0012137298001, received 2025-09-22.

Service providers paid directly by the plan

ProviderRelationshipService codesDirect compensationIndirect
MMA SECURITIES, LLCrecordkeeperINVESTMENT/FINANCIAL ADVI 15 Recordkeeping and information management; 21 Trustee (bank, trust company or similar); 49 Other services; 50 Direct payment from the plan; 64 Recordkeeping fees; 99 Other fees $65,987no
ADP, INC.recordkeeperRECORD KEEPER 37 Participant loan processing; 50 Direct payment from the plan; 15 Recordkeeping and information management; 64 Recordkeeping fees $6,885yes

Schedule C Part I line 2: name (a), service codes (b), relationship (c), direct compensation paid by the plan (d), indirect compensation received (e). Filing 20250922110923NAL0012137298001, received 2025-09-22.

What changed since the 2023 plan year

Figure20232024Change
Total assets$46,621,056$52,744,80213.1%
Participants with a balance433389-10.2%
Administrative expenses$71,660$72,8721.7%
Recordkeeping fees per participant$15.48$17.7014.3%
Employer contributions$1,838,297$1,459,978-20.6%

Prior filing 20240924052139NAL0022881442001, received 2024-09-24; the plan years are contiguous.

Alerts, claims and corrections

Alert me when this filing changes

One email when a new Form 5500 for Coherus Biosciences, Inc. 401(k) Plan appears in the Department of Labor data. Confirmation link first; unsubscribe link in every email.

Claim this plan

For the sponsor or its plan administrator: request to verify or annotate this page. A work email address at the sponsor speeds up verification.

Report a correction

Every figure is reproduced from the filing with its source. Tell us which figure and what the filing says instead.

Sponsor name as filed: COHERUS BIOSCIENCES, INC.; SEC registrant: Coherus Oncology, Inc. (CIK 1512762, matched by EIN; display name from the Form 10-K cover).